Immunoglobulin F(ab’)2 fragments of equine origin (solution for dilution for infusion).

Indication

Indicated for the treatment of envenomation (grade II or III) by European vipers (Vipera aspisVipera berusVipera ammodytes).

Description

VIPERFAV is a preparation containing equine immunoglobulin F(ab’)2 fragments which have the property of neutralising the venom of three species of vipers: Vipera aspisVipera berusVipera ammodytes.

These equine immunoglobulin F(ab’)2 fragments fix the venom antigens present in the blood in the form of inactive F(ab’)2-antigen complexes, reducing the level of free venom in the blood.

The product has a Marketing Authorisation (34009 562 154 09) granted by ANSM.

VIPERFAV is distributed in France by Inresa Pharma (www.inresa-pharma.fr). For product enquires please contact Inresa Pharma. 

VIPERFAV is distributed in all other countries by Flynn Pharma (www.flynnpharma.com).  For product enquiries please contact Flynn Pharma.